These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6985460)

  • 1. Human T-cell cultures with selective autotumor reactivity.
    Vánky F; Klein E
    Cancer Immunol Immunother; 1982; 14(2):73-7. PubMed ID: 6985460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.
    Vánky F; Gorsky T; Gorsky Y; Masucci MG; Klein E
    J Exp Med; 1982 Jan; 155(1):83-95. PubMed ID: 6459402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A; Moore M
    J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
    Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
    Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.
    Lotze MT; Grimm EA; Mazumder A; Strausser JL; Rosenberg SA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4420-5. PubMed ID: 6975652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytolysis of autologous fresh osteosarcoma cells by human cytotoxic T lymphocytes propagated with T cell growth factor.
    Ichino Y; Ishikawa T
    Gan; 1983 Aug; 74(4):584-94. PubMed ID: 6605270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell growth factor from human splenic cell cultures: conditions for its production, and its utilization for maintenance of cytotoxic T cell lines.
    Tanaka Y; Sugamura K; Hinuma Y
    Microbiol Immunol; 1981; 25(10):1077-86. PubMed ID: 6273698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome abnormality in a human TCGF-dependent T-lymphocyte culture generated against autologous melanoma cells in vitro.
    Knuth A; Jhanwar SC; Chaganti RS
    Cancer Genet Cytogenet; 1983 Nov; 10(3):277-82. PubMed ID: 6605190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and phenotypic characteristics of effusion-associated lymphoid cells cultured in the presence of either recombinant interleukin 2 or T-cell growth factor from malignant pleural and peritoneal effusions in patients with advanced carcinoma.
    Ebihara T; Koyama S
    Tohoku J Exp Med; 1990 Sep; 162(1):49-63. PubMed ID: 2077678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of human cytotoxic T lymphocytes against autologous solid tumors by autologous mixed lymphocyte tumor cell culture with T cell growth factor.
    Ichino Y; Ishikawa T
    Auris Nasus Larynx; 1985; 12 Suppl 2():S226-33. PubMed ID: 2942136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of human cytotoxic T lymphocytes against fresh autologous and allogeneic solid tumors by mixed lymphocyte tumor cell culture with T cell growth factor.
    Ichino Y; Ishikawa T
    Gan; 1984 May; 75(5):436-41. PubMed ID: 6235143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
    Itoh K; Tilden AB; Balch CM
    Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma.
    Apiranthitou-Drogari M; Paganin C; Bernasconi S; Losa G; Maneo A; Colombo N; Mantovani A; Allavena P
    Cancer Immunol Immunother; 1992; 35(4):289-95. PubMed ID: 1387344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor reactivity in vitro and in vivo of lymphocytes from normal donors and cancer patients propagated in culture with T cell growth factor (TCGF).
    Kedar E; Ikejiri BL; Timonen T; Bonnard GD; Reid J; Navarro NJ; Sredni B; Herberman RB
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):757-73. PubMed ID: 6603361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of T lymphocytes propagated from human lung carcinomas.
    Kurnick JT; Kradin RL; Blumberg R; Schneeberger EE; Boyle LA
    Clin Immunol Immunopathol; 1986 Mar; 38(3):367-80. PubMed ID: 3080265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T lymphocytes grown in T-cell growth factor: functional attributes in MLC, CML, PLT and allogeneic suppression.
    Pawelec G; Rehbein A; Müller C; Sonneborn HH; Wernet P
    Immunology; 1981 Apr; 42(4):529-40. PubMed ID: 6453828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors.
    Heo DS; Whiteside TL; Kanbour A; Herberman RB
    J Immunol; 1988 Jun; 140(11):4042-9. PubMed ID: 3286766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
    Uchida A; Moore M; Klein E
    Int J Cancer; 1988 May; 41(5):651-6. PubMed ID: 2966771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A; Klein E
    J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.